焦虑
苦恼
代谢组学
亚临床感染
临床心理学
心理学
人口
精神科
医学
生物信息学
内科学
生物
环境卫生
作者
Yiwen Zhu,Shaili C. Jha,Katherine Hoff Shutta,Tianyi Huang,Raji Balasubramanian,Clary B. Clish,Susan E. Hankinson,Laura Diane Kubzansky
标识
DOI:10.1016/j.neubiorev.2022.104954
摘要
Psychological distress can be conceptualized as an umbrella term encompassing symptoms of depression, anxiety, posttraumatic stress disorder (PTSD), or stress more generally. A systematic review of metabolomic markers associated with distress has the potential to reveal underlying molecular mechanisms linking distress to adverse health outcomes. The current systematic review extends prior reviews of clinical depressive disorders by synthesizing 39 existing studies that examined metabolomic markers for PTSD, anxiety disorders, and subclinical psychological distress in biological specimens. Most studies were based on small sets of pre-selected candidate metabolites, with few metabolites overlapping between studies. Vast heterogeneity was observed in study design and inconsistent patterns of association emerged between distress and metabolites. To gain a more robust understanding of distress and its metabolomic signatures, future research should include 1) large, population-based samples and longitudinal assessments, 2) replication and validation in diverse populations, 3) and agnostic metabolomic strategies profiling hundreds of targeted and nontargeted metabolites. Addressing these research priorities will improve the scope and reproducibility of future metabolomic studies of psychological distress.
科研通智能强力驱动
Strongly Powered by AbleSci AI